Overview

Leverage prescription benefit insights at the right time

When cost or coverage issues delay important care, it’s an unwelcome surprise for everyone involved. High costs harm adherence. A prior authorization process that depends on faxes and forms takes up valuable time and attention.

Surescripts shares accurate clinical and benefit intelligence when and where it’s needed, making it easy to choose the best option for each patient and expedite (or avoid unnecessary) prior authorizations.

$37

average Real-Time Prescription Benefit savings/prescription ($785 for specialty medications)1

3.2

percentage-point pickup rate gain with Real-Time Prescription Benefit2

Just under 4

minutes to receive a prior authorization response on average3

The Surescripts Platform

Powering the future of healthcare

Health intelligence sharing at scale requires powerful infrastructure. The Surescripts Platform supports every Surescripts product and every Network Alliance participant with industry-leading reliability, security and scalability.

platform image
bg
Success Stories

Real-world results

“[With Real-Time Prescription Benefit I can] turn my computer screen to my patient and family members and say, 'I have this medication in mind, but let's look at it together and see what your costs will be.'”

Dr. Michelle Forbes Physician, MD Pediatric Associates

“We are finishing 10 electronic prior authorizations in the time it takes to finish one or two manually during a day.”

Candace Minter, Pharm.D. Pharmacy Operations Manager, Sentara Medical Group
Insights

Keep pace with healthcare innovation

Footnotes:
  1. Surescripts, "2023 National Progress Report," March 2024.
  2. Surescripts, “2022 National Progress Report,” March 2023.
  3. Surescripts, “2022 Medication Affordability & Adherence Impact Report,” September 2022.
  4. CAQH, “2020 CAQH Index: Closing the Gap: The Industry Continues to Improve, But Opportunities for Automation Remain,” 2021: p. 6.
  5. Jaime Y. Smith et al., “E-Prescribing with Decision Support Is Associated with Improvements in Medication Adherence,” The American Journal of Pharmacy Benefits 8, no. 4, (August 17, 2016).
  6. Surescripts, “2021 National Progress Report,” January 2022.
  7. Denise Clayton et al., “Evaluation of the Fast Prior Authorization Technology Highway,” Journal of the American Pharmacists Association 62, no. 6 (December 2022): 1843–1847.
Read More